Abstract Taxanes play pivotal roles across therapeutic stages of triple-negative breast cancer (TNBC), yet their efficacy is substantially limited by drug resistance and systemic toxicity. Immunotherapy has been found to enhance the efficacy of chemotherapy. Here, we investigated the synergistic antitumor activity between taxanes and γδ-T cells, a major histocompatibility complex-independent T cell subset with potent cytotoxic activity against tumor cells.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Meize
Contact Meize, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack